DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and ...
Existing treatment options, which include hearing aids or bone conduction devices, often fail to address these issues because they generally only serve to reroute sound signals from one ear to the ...
A study from Ann & Robert H. Lurie Children's Hospital of Chicago found that children with a MED-EL Synchrony cochlear implant device can undergo MRI safely, with no discomfort and reduced need for ...
11-year-old DuJuan Broadus is the first U.S. patient to receive a MED-EL FLEX34 cochlear implant, designed for those with a larger cochlea. The new implant allows for a wider range of frequencies, ...
The cochlear implant systems that we know today with small designs and built-in future-ready technology have come a long way since Austrian scientists Ingeborg and Erwin Hochmair began working on ...
The FDA has approved SYNCHRONY and SYNCHRONY 2 (MED-EL) cochlear implant systems for single-sided deafness and asymmetric hearing loss. The Food and Drug Administration (FDA) has approved SYNCHRONY ...
DURHAM, N.C., April 29, 2026--(BUSINESS WIRE)--Hearing implant leader MED-EL USA is announcing two upcoming symposia at CI2026, the annual meeting of the American Cochlear Implant Association (ACIA) ...
MED-EL’s are the First and Only Cochlear Implants to Be Granted Indications for Traditionally Underserved Population MED-EL Cochlear Implant Systems, including the recently FDA-approved SYNCHRONY 2 ...
11-year-old DuJuan Broadus is the first U.S. patient to receive a MED-EL FLEX34 cochlear implant, designed for those with a larger cochlea. The new implant allows for a wider range of frequencies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results